Healthcare projects are taking the lead in decentralized science (DeSci) due to the rising challenges in bringing new drugs to market. Alex Dobrin from VitaDAO highlighted the growing dissatisfaction with biomedical research and the increasing time and cost of drug discovery. Eroom’s Law, which states the doubling of drug discovery costs every nine years, reflects this trend. Decentralized science projects, with 61% in healthcare, offer potential benefits like faster and cost-effective drug development. Blockchain technology is seen as a game-changer in clinical trials, improving efficiency and data security. The integration of decentralized and centralized medicine may blur in the future, with decentralized funding playing a key role in de-risking early-stage research. Overall, the shift towards decentralized healthcare aims to revolutionize the pharmaceutical industry and enhance patient outcomes. Read more AI-generated news on: https://app.chaingpt.org/news